# A Study to Evaluate Indocyanine Green Lymphangiography to Improve Lymphadenectomy in Gastric Cancer Patients

> **NCT04591028** · PHASE4 · WITHDRAWN · sponsor: **Mayo Clinic**

## Conditions studied

- Gastric Cancer

## Interventions

- **DRUG:** Indocyanine green

## Key facts

- **NCT ID:** NCT04591028
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2022-01
- **Primary completion:** 2022-01
- **Final completion:** 2022-08-10
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Lack of funding.
- **Last updated:** 2023-07-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04591028

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04591028, "A Study to Evaluate Indocyanine Green Lymphangiography to Improve Lymphadenectomy in Gastric Cancer Patients". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04591028. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*